GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oventus Medical Ltd (ASX:OVN) » Definitions » Debt-to-EBITDA

Oventus Medical (ASX:OVN) Debt-to-EBITDA : -0.05 (As of Dec. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Oventus Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Oventus Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was A$0.20 Mil. Oventus Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2021 was A$0.24 Mil. Oventus Medical's annualized EBITDA for the quarter that ended in Dec. 2021 was A$-8.94 Mil. Oventus Medical's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2021 was -0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Oventus Medical's Debt-to-EBITDA or its related term are showing as below:

ASX:OVN's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

Oventus Medical Debt-to-EBITDA Historical Data

The historical data trend for Oventus Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oventus Medical Debt-to-EBITDA Chart

Oventus Medical Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21
Debt-to-EBITDA
- - - -0.01 -0.06

Oventus Medical Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.08 -0.06 -0.05

Competitive Comparison of Oventus Medical's Debt-to-EBITDA

For the Medical Devices subindustry, Oventus Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oventus Medical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oventus Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oventus Medical's Debt-to-EBITDA falls into.



Oventus Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Oventus Medical's Debt-to-EBITDA for the fiscal year that ended in Jun. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.219 + 0.32) / -8.473
=-0.06

Oventus Medical's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.203 + 0.24) / -8.942
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2021) EBITDA data.


Oventus Medical  (ASX:OVN) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Oventus Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Oventus Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Oventus Medical (ASX:OVN) Business Description

Traded in Other Exchanges
N/A
Address
1 Swann Road, Suite 1, PO Box 190, Indooroopilly, Brisbane, QLD, AUS, 4068
Oventus Medical Ltd is a medical device company. It is engaged in developing an oral appliance for the treatment of sleep apnoea and snoring. Its product includes O2Vent Optima . It offers oral appliance therapy, especially beneficial for the many people that suffer from nasal congestion, obstruction, and mouth breathing. The firm has two operating segments: Australia and North America.

Oventus Medical (ASX:OVN) Headlines

No Headlines